rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
19
|
pubmed:dateCreated |
2004-11-19
|
pubmed:abstractText |
Electrocardiographic left ventricular hypertrophy (LVH) is a strong predictor of cardiovascular (CV) morbidity and mortality. However, the predictive value of changes in the magnitude of electrocardiographic LVH criteria during antihypertensive therapy remains unclear.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1538-3598
|
pubmed:author |
pubmed-author:AurupPeterP,
pubmed-author:DahlöfBjörnB,
pubmed-author:DevereuxRichard BRB,
pubmed-author:EdelmanJonathan MJM,
pubmed-author:HarrisKatherine EKE,
pubmed-author:JernSverkerS,
pubmed-author:JuliusStevoS,
pubmed-author:KjeldsenSverre ESE,
pubmed-author:LIFE Study Investigators,
pubmed-author:LindholmLars HLH,
pubmed-author:NieminenMarkku SMS,
pubmed-author:OkinPeter MPM,
pubmed-author:SnapinnStevenS,
pubmed-author:WedelHansH
|
pubmed:issnType |
Electronic
|
pubmed:day |
17
|
pubmed:volume |
292
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2343-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15547161-Aged,
pubmed-meshheading:15547161-Antihypertensive Agents,
pubmed-meshheading:15547161-Atenolol,
pubmed-meshheading:15547161-Blood Pressure,
pubmed-meshheading:15547161-Cardiovascular Diseases,
pubmed-meshheading:15547161-Electrocardiography,
pubmed-meshheading:15547161-Female,
pubmed-meshheading:15547161-Humans,
pubmed-meshheading:15547161-Hypertension,
pubmed-meshheading:15547161-Hypertrophy, Left Ventricular,
pubmed-meshheading:15547161-Losartan,
pubmed-meshheading:15547161-Male,
pubmed-meshheading:15547161-Middle Aged,
pubmed-meshheading:15547161-Morbidity,
pubmed-meshheading:15547161-Prognosis,
pubmed-meshheading:15547161-Proportional Hazards Models,
pubmed-meshheading:15547161-Randomized Controlled Trials as Topic
|
pubmed:year |
2004
|
pubmed:articleTitle |
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
|
pubmed:affiliation |
Department of Medicine, Division of Cardiology, Cornell University Medical Center, New York, NY 10021, USA. pokin@mail.med.cornell.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|